“It is simply unacceptable that unclear or outdated legal frameworks could hinder deployment,” said BIS General Manager Agustín Carstens. Source: https://decrypt.co/199007/the-law-must-evolve-to-make-cbdcs-possible-says-bis-chief

Mixed reality at a fraction of the price of the Apple Vision Pro. Will it be worth it? Here’s the latest on the Meta Quest 3. Source: https://decrypt.co/199046/meta-quest-3-everything-you-need-to-know

The SEC made the call this week, even though it wasn’t required to issue a decision until November 11. Source: https://decrypt.co/198888/sec-delays-spot-bitcoin-etf-decision-second-time

Dave Lemke is the CFO & CCO at Giddy, creators of a self-custody crypto wallet with decentralized private key security. Stacy Elliott interviewed him at Messari Mainnet 2023. Source: …

Amanda Tuminelli serves as the DeFi Education Fund’s Chief Legal Officer where she leads the organization’s impact litigation and policy efforts. Stacy Elliott of Decrypt interviewed her at Messari …

South Korea’s largest cryptocurrency exchange halted deposits after detecting what it said was an abnormal amount of deposit attempts related to a scam token. Source: https://decrypt.co/198551/south-koreas-upbit-temporarily-freezes-withdrawals-following-scam-token-airdrop

Customers who connect online services to the NFT marketplace are told to swap out their keys. Source: https://decrypt.co/198496/opensea-api-users-warned-of-third-party-security-breach

Authorities say the machines were found when 11,000 troops raided the Tocorón prison this week. Source: https://decrypt.co/198425/police-seize-bitcoin-mining-machines-prison-bust-venezuela

Another notable South Korean publisher embraces blockchain gaming, this time on Sui in partnership with Mysten Labs. Source: https://decrypt.co/198238/south-korean-mobile-developer-nhn-building-crypto-games-sui

Neuralink is ready to take things to the inevitable next level, testing its brain-reading chip in humans. Source: https://decrypt.co/198110/neuralink-brain-implant-chip-human-testing-fda